Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aetna Inc Reaffirms FY 2013 Guidance; Updates On Acquisition Of Coventry Health Care Inc-Reuters


Monday, 7 Jan 2013 06:08pm EST 

Reuters reported that Aetna Inc reaffirmed profit and revenue outlook for fiscal 2013 and said as of last week it had received 17 of the 21 state approvals needed for its planned acquisition of smaller rival Coventry Health Care Inc. Aetna continues to expect fiscal 2013 operating earnings of at least $5.40 a share, on a 9% increase in revenue, reiterating the forecast it gave in mid-December. Aetna plans to buy Coventry for $5.6 billion. 

Company Quote

84.58
-0.29 -0.34%
23 Jul 2014